Literature DB >> 11483401

Three patients with ophthalmoplegia associated with Campylobacter jejuni.

S Kuroki1, T Saida, M Nukina, M Yoshioka, J Seino.   

Abstract

Cranial polyneuropathy is idiopathic in most patients. Idiopathic cranial polyneuropathy is an acute postinfectious syndrome, along with Guillain-Barré syndrome and Miller Fisher syndrome, in which the common preceding pathogen is Campylobacter jejuni. Serum anti-GQ1b antibodies are elevated in Miller Fisher syndrome and Guillain-Barré syndrome with ophthalmoplegia. Three patients with idiopathic cranial polyneuropathy with predominant ocular involvement are presented. C. jejuni isolated from stool specimens belonged to Penner serotypes O:4, O:23, and O:33. Serum anti-GQ1b antibodies were elevated in all patients but demonstrated rapid reduction concomitant with clinical recovery. All patients recovered completely. Because both preceding C. jejuni infection and elevated anti-GQ1b antibodies decreasing with time were seen in all patients, the pathogenesis of idiopathic cranial polyneuropathy with ophthalmoplegia may be similar to that of Miller Fisher syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483401     DOI: 10.1016/s0887-8994(01)00281-8

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Acute isolated ophthalmoplegia with anti-GQ1b antibodies.

Authors:  Andrea Rigamonti; Giuseppe Lauria; Marco Longoni; Lorenzo Stanzani; Elio Agostoni
Journal:  Neurol Sci       Date:  2011-02-19       Impact factor: 3.307

2.  Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi.

Authors:  Y L Lo; L L Chan; A Pan; P Ratnagopal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

3.  Steroid Responsive Acute Isolated Ophthalmoplegia: A Rare Presentation of Anti-Gq1b Antibodies Syndrome.

Authors:  Divyani Garg; V Y Vishnu; M B Singh; Vinay Goyal; M V Padma Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2020-12-08       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.